Alex Sapir, Former CEO of ReViral Ltd. and Dova Pharmaceuticals, on Advancing Pipeline Candidates and Financing Biotech Companies

LifeSci Beat by Wharton Health Care

Episode notes

In the eighth episode of this season, we chatted with Alex Sapir about his various experiences leading life sciences companies through commercial launches and key funding milestones. We spoke about his career beginnings at GSK, ZS Associates, and United Therapeutics. Additionally, we covered his CEO tenures at Dova Pharmaceuticals and ReViral Ltd - both of which were acquired.